EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...

Remedy Pharmaceuticals, the developer of CIRARA (intravenous glyburide) for the treatment of Large Hemispheric Infarction (LHI) today announced three speaker presentations of efficacy data from both ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...

Large-scale controlled trials in men airlifted from ... prevention of acute mountain sickness and high-altitude pulmonary edema in fresh entrants as well as former residents.

Emergency medical services were activated; the fingerstick blood glucose level was normal, and the Glasgow Coma Scale score was 15 ... consistent with vasogenic edema with resultant mild ...

Laser therapy for acne vulgaris is a safe and effective option as both an alternative or adjunctive therapy across skin types.

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was ...

“The stress from shoveling snow combined with the bitter cold can be dangerous, causing an increase in blood flow and blood ...

A monthly 10 mg/mL maintenance dose of Leqembi had the same effects on mild Alzheimer’s symptoms as biweekly dose, research ...